Literature DB >> 8567412

Glutathione protection against gentamicin ototoxicity depends on nutritional status.

J Lautermann1, J McLaren, J Schacht.   

Abstract

This study demonstrates that gentamicin ototoxicity depends on dietary factors and correlates with tissue glutathione levels. After 15 days of gentamicin injections (100 mg/kg/day s.c.) guinea pigs on a regular protein diet (18.5% protein) had an average hearing loss of 9 dB at 3 kHz, 31 dB at 8 kHz and 42 dB at 18 kHz. Guinea pigs on a 7% protein diet showed an increased hearing loss of 52 dB at 3 kHz, 63 dB at 8 kHz and 74 dB at 18 kHz. Supplementing the low protein diet with either essential or sulfur-containing amino acids did not protect against gentamicin ototoxicity. Glutathione levels in the cochlear sensory epithelium were decreased in animals on a low protein diet and could be restored to normal by oral administration of glutathione monoethyl ester (1.2 g/kg/day) in combination with vitamin C (100 mg/kg/day). Glutathione supplementation significantly reduced the magnitude of hearing loss in the low protein diet group at all frequencies (43 dB reduction at 3 kHz, 27 dB reduction at 8 kHz and 21 dB reduction at 18 kHz). In animals on a full protein diet, dietary glutathione neither increased cochlear glutathione levels nor attenuated hearing loss. Serum gentamicin levels did not differ between animals on the various diets with or without glutathione supplement. These results suggest that gentamicin toxicity and detoxifying mechanisms are affected by the metabolic state of the animal and the glutathione content of the tissue. Thus, compounds that could potentially protect against gentamicin ototoxicity may be more correctly assessed in animal models of deficient nutritional states in which endogenous detoxifying mechanisms are compromised. This animal model might also be more realistically related to the clinical situation of a critically ill patient receiving gentamicin treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567412     DOI: 10.1016/0378-5955(95)00049-a

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  21 in total

Review 1.  Future approaches for inner ear protection and repair.

Authors:  Seiji B Shibata; Yehoash Raphael
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

2.  Pharmacokinetics of Drug Entry into Cochlear Fluids.

Authors:  Alec N Salt
Journal:  Volta Rev       Date:  2005

3.  In vivo imaging of mammalian cochlear blood flow using fluorescence microendoscopy.

Authors:  Ashkan Monfared; Nikolas H Blevins; Eunice L M Cheung; Juergen C Jung; Gerald Popelka; Mark J Schnitzer
Journal:  Otol Neurotol       Date:  2006-02       Impact factor: 2.311

Review 4.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

5.  Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.

Authors:  Douglas Ruhl; Ting-Ting Du; Elizabeth L Wagner; Jeong Hwan Choi; Sihan Li; Robert Reed; Kitae Kim; Michael Freeman; George Hashisaki; John R Lukens; Jung-Bum Shin
Journal:  J Neurosci       Date:  2019-02-07       Impact factor: 6.167

Review 6.  Monitoring neonates for ototoxicity.

Authors:  Angela C Garinis; Alison Kemph; Anne Marie Tharpe; Joern-Hendrik Weitkamp; Cynthia McEvoy; Peter S Steyger
Journal:  Int J Audiol       Date:  2017-06-22       Impact factor: 2.117

Review 7.  Survival of auditory hair cells.

Authors:  Michelle L Seymour; Fred A Pereira
Journal:  Cell Tissue Res       Date:  2015-03-07       Impact factor: 5.249

Review 8.  Intracellular mechanisms of aminoglycoside-induced cytotoxicity.

Authors:  Takatoshi Karasawa; Peter S Steyger
Journal:  Integr Biol (Camb)       Date:  2011-07-29       Impact factor: 2.192

Review 9.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

10.  Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics.

Authors:  Hongzhe Li; Peter S Steyger
Journal:  Noise Health       Date:  2009 Jan-Mar       Impact factor: 0.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.